Cullinan Oncology, Inc. (CGEM) Tops Q4 EPS by 6c

Cullinan Oncology, Inc. (NASDAQ: CGEM) reported Q4 EPS of ($0.73), $0.06 better than the analyst estimate of ($0.79).

For earnings history and earnings-related data on Cullinan Oncology, Inc. (CGEM) click here.

You May Also Be Interested In

• OneMain (OMF) Reiterated at Market Outperform by Citizens on Updated Estimates
• JPMorgan Upgrades IBM (IBM) to Overweight
• Signify and Silicon Labs add dual-protocol support to Philips Hue bulbs